Elevated Activation of ERK1 and ERK2 Accompany Enhanced Liver Injury Following Alcohol Binge in Chronically Ethanol-Fed Rats

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 12, 2011, Pages 2128-2138

  Aroor, Annayya R ^a   Jackson, Daniel E ^a   Shukla, Shivendra D ^a  

^a University of Missouri   (United States)

Author keywords

Alcoholic Steatohepatitis; Binge Ethanol; Chronic Ethanol; Liver Injury; MAPK; Necrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; CASPASE 3; EARLY GROWTH RESPONSE FACTOR 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE RSK; PLASMINOGEN ACTIVATOR INHIBITOR 1; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINGE DRINKING; BODY WEIGHT; CONTROLLED STUDY; DRINKING BEHAVIOR; ENZYME ACTIVATION; FATTY LIVER; GENE EXPRESSION; HISTOPATHOLOGY; LIPID LIVER LEVEL; LIVER INJURY; LIVER NECROSIS; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALCOHOL DRINKING; ANIMALS; DRUG-INDUCED LIVER INJURY, CHRONIC; ENZYME ACTIVATION; ETHANOL; FATTY LIVER, ALCOHOLIC; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 81855221834     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2011.01577.x     Document Type: Article

References (57)

1. Adachi M, Brenner DA (2005) Clinical syndromes of alcoholic liver disease. Dig Dis 23:255-263.
2. Amersi F, Shen X-D, Anselmo D, Anselmo D, Melinek J, Iyer S, Southard DJ, Katori M, Volk HD, Busuttil RW, Buelow R, Kupiec-Weglinski JW (2002) Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 35:815-823.
3. Anjum R, Blenis J (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9:747-758.
4. Apte M, McCarroll J, Pirola R, Wilson J (2007) Pancreatic MAP kinase pathways and acetaldehyde. Novartis Found Symp 285:200-211.
5. Aroor AR, Custer GW, Weng YI, Lee YJ, Shukla SD (2002) Phosphatidylethanol mimics ethanol modulation of p42/44 mitogen-activated protein kinase signalling in hepatocytes. Alcohol Alcohol 37:534-539.
6. Aroor AR, Jackson DE, Shukla SD (2010) Chronic ethanol intake increases susceptibility to liver injury by repeat ethanol binge: a novel clinically relevant model for progression of alcoholic liver injury. Alcohol Clin Exp Res 34:144A.
7. Aroor AR, Shukla SD (2004) MAP kinase signaling in diverse effects of ethanol. Life Sci 74:2339-2364.
8. Aroor AR, Shukla SD (2009) Activation of ERK1/2 MAP kinase in liver after binge and chronic ethanol-binge intake may augment liver injury. FASEB J 23:225A.
9. Beier JI, Luyendyk JP, Guo L, von Montfort C, Staunton DE, Arteel GE (2009) Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice. Hepatology 49:1545-1553.
10. Bhagwandeen BS, Apte M, Manwarring L, Dickeson J (1987) Endotoxin induced hepatic necrosis in rats on an alcohol diet. J Pathol 152:47-53.
11. Boutros T, Chevet E, Metrakos P (2008) Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev 60:261-310.
12. Buck M, Chojkier M (2007) A ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis. PLoS One 2:e1372.
13. Caro AA, Cederbaum AI (2006) Role of cytochrome p450 in phospholipase A2-arachidonic acid mediated toxicity. Free Radical Med Biol 40:364-375.
14. Ceccanti M, Attili A, Balducci G, Attilia F, Giacomelli S, Rotondo C, Sasso GF, Xirouchakis E, Attilia ML (2006) Acute alcoholic hepatitis. J Clin Gastroenterol 40:833-841.
15. Crosse KI, Anania FK (2002) Alcoholic hepatitis. Curr Treat Options Gastroenterol 5:417-423.
16. Deaciuc D IV, Souza NB, Burkhanov R, Nasser MS, Voskresensky IV, De Villiers WJ, McClain CJ (2004) Alcohol but not lipopolysaccharide-induced liver apoptosis involves changes in intracellular compartmentalization of apoptotic regulators. Alcohol Clin Exp Res 28:160-172.
17. Ericson J, Rutberg M, Magnusson B, Andersson L, Boström P (2006) PLD1 and ERK2 regulate cytosolic lipid droplet formation. J Cell Sci 119:2246-2257.
18. Fukui H (2005) Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic injury and multiple organ failure. Alcohol Clin Exp Res 29:172S-179S.
19. Fukumura A, Tsutsumi M, Tsuchishima M, Takase S (2003) Correlation between adenosine triphosphate content and apoptosis in liver treated with alcohol. Alcohol Clin Exp Res 27:12S-15S.
20. de la Hall MP, Lieber CS, DeCarli LM, French SW, Lindros KO, Jarvelainen H, Bode C, Parlesak A, Bode JC (2001) Models of alcoholic liver disease in rodents. A critical evaluation. Alcohol Clin Exp Res 25:254S-261S.
21. Honchel R, Ray MB, Marsano L, Cohen D, Lee E, Shedlosky S, McClain CJ (1992) Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res 16:665-669.
22. Hsu MKH, Qiao L, Ho VB, Zhang H, Zhang H, Teoh N, Dent P, Farrrel GC (2006) Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in rats. J Hepatol 44:375-382.
23. Ji C, Deng Q, Kaplowitz N (2004) Role of TNF-α in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. Hepatology 40:442-451.
24. Kaizu T, Ikeda A, Nakao A (2008) Protection of transplant induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway down regulation. Am J Physiol Gastrointest Liver Physiol 294:G236-G244.
25. Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R, Gao B (2010) Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52:1291-1300.
26. Kotesh A, Yang S, Lin H, Huang X, Diehl AM (2002a) Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting jun N-terminal kinase and caspase 3 activation. J Biol Chem 44:13037-13044.
27. Kotesh A, Yang S, Lin H, Huang J, Diehl AM (2002b) Ethanol induces redox-sensitive cell-cycle inhibitors and inhibits liver regeneration after partial hepatectomy. Alcohol Clin Exp Res 26:1710-1718.
28. Lee YJ, Aroor AR, Shukla SD (2002) Temporal activation of p42/44 MAPK and C-Jun N-terminal kinase by acetaldehyde in rat hepatocytes and its loss after chronic ethanol exposure. J. Pharm Exp Ther 301:908-914.
29. Lee YJ, Shukla SD (2005) Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes. Eur J Pharmacol 508:31-45.
30. Lee YJ, Shukla SD (2007) Histone H3 phosphorylation at serine 10 and serine 28 is mediated by p38 MAPK in rat hepatocytes exposed to ethanol and acetaldehyde. Eur J Pharmacol 573:29-38.
31. Lieber CS, De Carli LM (1982) The feeding of alcohol and liquid diets: two decades of applications and 1982 update. Alcohol Clin Exp Res 6:523-531.
32. Liu Q, Möller U, Flügel D, Kietzmann T (2004) Induction of plasminogen activator inhibitor I gene expression by intracellular calcium via hypoxia-inducible factor-1. Blood 104:3993-4001.
33. Mandrekar P, Szabo G (2009) Signalling pathways in alcohol-induced liver inflammation. J Hepatol 50:1258-1266.
34. Mathurin P, Beuzin F, Louvet A, Carrié-Ganne N, Balian A, Trinchet JC, Dalsoglio D, Prevot S, Naveau S (2007) Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther 25:1047-1054.
35. Mathurin P, Deltenre P (2009) Effect of binge drinking on the liver: an alarming public health issue? Gut 58:613-617.
36. Mor A, Philips MR (2006) Compartmentalized Ras/MAPK signaling. Annu Rev Immunol 24:771-800.
37. Nelson S, Baghy GJ, Bainton BG, Summer WR (1989) The effects of acute and chronic alcoholism on tumor necrosis factor and the inflammatory response. J Inf Dis 160:422-429.
38. Nguyen VA, Gao B (2002) Expression of interferon alfa signaling components in human alcoholic liver disease. Hepatology 35:425-432.
39. Ni HM, Chen X, Ding WX, Schuchmann M, Yin X (2008) Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice. Am J Pathol 173:962-972.
40. Oguro T, Takahasi Y, Ashino T, Takaki A, Shidoja S, Horai R, Asano M, Sekikawa K, Iwakura Y, Yoshida T (2002) Involvement of tumor necrosis factor alpha rather than interleukin 1-α/β or nitric oxides in the heme oxygenase-1 gene expression by lipopolysaccharide in the mouse liver. FEBS Lett 516:63-66.
41. Park PH, Lim RW, Shukla SD (2005) Involvement of histone acetyltransferase (HAT) in ethanol-induced acetylation of histone H3 in hepatocytes: potential mechanism for gene expression. Am J Physiol Gastrointest Liver Physiol 289:G1124-G1136.
42. Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarençon D, Agay D, Chancerelle Y, Multon E (2004) Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 5:3.
43. Pimienta G, Pascual J (2007) Canonical and alternative MAPK signaling. Cell Cycle 6:2628-2632.
44. Pritchard MT, Nagy LE (2005) Ethanol-induced liver injury: potential roles for egr-1. Alcohol Clin Exp Res 11(Suppl):146S-150S.
45. Rivara PF, Jurkovich GJ, Gurney JG, Seguin D, Fligner CL, Ries R, Raisys VA, Copass M (1993) The magnitude of acute and chronic alcohol abuse in trauma patients. Arch Surg 128:907-913.
46. Schafer C, Parlesak A, Schutt C (2002) Concentrations of lipopolysaccharide binding protein, bactericidal/permeability-increasing protein, soluble CD-14 and plasma lipids in relation to endotoxemia in patients with alcoholic liver disease. Alcohol Alcohol 37:81-86.
47. Schattenberg JM, Wang Y, Rigoli RM, Koop DR, Czaja MJ (2004) CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling. Hepatology 39:444-455.
48. Shimamura A, Ballif BA, Richards SA, Blenis J (2000) Rsk1 mediates a MEK-MAP kinase survival signal. Curr Biol 10:127-135.
49. Singh R, Wang Y, Xiang Y (2009) Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology 49:87-96.
50. Thakur V, McMullen MR, Pritchard MT, Nagy LE (2007) Regulation of macrophage activation in alcoholic liver disease. J Gastroenterol Hepatol 22:S53-S56.
51. Tsai JC, Liu L, Zhang J, Spokes KC, Topper JN, Aird WC (2001) Epidermal growth factor induces Egr-1 promoter activity in hepatocytes in vitro and in vivo. Am J Physiol Gastrointest Liver Physiol 281:G1271-G1278.
52. Venugopal SK, Chen J, Zhang Y, Clemens D, Follenzi A, Zern MA (2007) Role of MAPK phosphatase-1 in sustained activation of JNK during ethanol-induced apoptosis in hepatocyte-like VL-17A cells. J Biol Chem 282:31900-31908.
53. Wheeler MD, Thurman RG (2003) Up-regulation of CD14 in liver caused by acute ethanol involves oxidant-dependent AP-1 pathway. J Biol Chem 278:8435-8441.
54. Xiong Y, Collins QF, An J, Lupo E Jr, Liu HY, Liu D, Robidoux J, Liu Z, Cao W (2007) p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis. J Biol Chem 282:4975-4982.
55. Yamagishi Y, Horie Y, Kato S, Kajihara S, Tamai H, Granger DN, Ishii H (2002) Ethanol modulates gut ischemia/reperfusion-induced injury in rats. Am J Physiol Gastrointest Liver Physiol 282:G640-G646.
56. You M, Liang X, Ajmo JM, Ness GC (2008) Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol 294:G892-G898.
57. Zakhari S, Li TK (2007) Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology 46:2032-2039.